Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Expert Opinion on Therapeutic Patents
|
October 17, 2023
Proteasome inhibitors as anticancer agents
Giorgia Gazzaroli, Andrea Angeli, Arianna Giacomini, et al.
Experimental Hematology & Oncology
|
November 2, 2022
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
Marta Turati, Arianna Giacomini, Sara Rezzola, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 1, 2024
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, et al.
ACS Pharmacology & Translational Science
|
November 14, 2024
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist
Maria De Fenza, Filippo Locri, Flavia Plastino, et al.
Experimental Hematology & Oncology
|
August 8, 2025
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo
Giorgia Gazzaroli, Camilla Tavani, Serena Filiberti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma
Sara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 23, 2025
Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677]
Sara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Pharmacological Research
|
July 5, 2024
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
Sara Taranto, Riccardo Castelli, Giuseppe Marseglia, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Expert Opinion on Therapeutic Patents
|
October 17, 2023
Proteasome inhibitors as anticancer agents
Giorgia Gazzaroli, Andrea Angeli, Arianna Giacomini, et al.
Experimental Hematology & Oncology
|
November 2, 2022
The natural FGF-trap long pentraxin 3 inhibits lymphangiogenesis and lymphatic dissemination
Marta Turati, Arianna Giacomini, Sara Rezzola, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 1, 2024
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, et al.
ACS Pharmacology & Translational Science
|
November 14, 2024
Turn-Adopting Peptidomimetic as a Formyl Peptide Receptor-1 Antagonist
Maria De Fenza, Filippo Locri, Flavia Plastino, et al.
Experimental Hematology & Oncology
|
August 8, 2025
An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo
Giorgia Gazzaroli, Camilla Tavani, Serena Filiberti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
October 22, 2025
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma
Sara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 23, 2025
Corrigendum to "FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma" [Biomed. Pharmacother. 192 (2025) 118677]
Sara Taranto, Jessica Faletti, Mariangela Tamburello, et al.
Pharmacological Research
|
July 5, 2024
Discovery of novel FGF trap small molecules endowed with anti-myeloma activity
Sara Taranto, Riccardo Castelli, Giuseppe Marseglia, et al.
Page
of 1